Dr. Oetker to turn profitable this year with a top line of Rs 340-345 crore

The company recently unveiled a new natural variant of its peanut butter range and also launched smaller 150 gram SKUs two months ago

After 12 years of operations in India, Germany-based Dr. Oetker, the market leader in mayonnaise in this country, is expected to break-even at the EBITDA level this year with a top line of Rs 340-345 crore.

It has targeted to reach revenues of Rs 500 crore in 2022.

The growth is majorly led by new stock keeping units (SKUs) the company introduced in recent times, extension of existing products and an increase in its outlet count.

“We had invested in a plant in Rajasthan in India which is spread across 15 acres and has an installed capacity of 46,000 tonnes.